314 related articles for article (PubMed ID: 2497234)
1. Platelet destruction in autoimmune thrombocytopenic purpura: kinetics and clearance of indium-111-labeled autologous platelets.
Stratton JR; Ballem PJ; Gernsheimer T; Cerqueira M; Slichter SJ
J Nucl Med; 1989 May; 30(5):629-37. PubMed ID: 2497234
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and sites of destruction of 111Indium-oxine-labeled platelets in idiopathic thrombocytopenic purpura: a quantitative study.
Heyns AD; Lötter MG; Badenhorst PN; de Kock F; Pieters H; Herbst C; van Reenen OR; Kotze H; Minnaar PC
Am J Hematol; 1982 Apr; 12(2):167-77. PubMed ID: 7200322
[TBL] [Abstract][Full Text] [Related]
3. [Kinetic study of indium-111 labelled platelets in idiopathic thrombocytopenic purpura (author's transl)].
Reiffers J; Vuillemin L; Broustet A; Ducassou D
Nouv Presse Med; 1982 Jul; 11(31):2335-8. PubMed ID: 7202192
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura.
Gernsheimer T; Stratton J; Ballem PJ; Slichter SJ
N Engl J Med; 1989 Apr; 320(15):974-80. PubMed ID: 2927480
[TBL] [Abstract][Full Text] [Related]
5. Splenectomy in idiopathic thrombocytopenic purpura: its correlation with the sequestration of autologous indium-111-labeled platelets.
Lamy T; Moisan A; Dauriac C; Ghandour C; Morice P; Le Prise PY
J Nucl Med; 1993 Feb; 34(2):182-6. PubMed ID: 8429334
[TBL] [Abstract][Full Text] [Related]
6. [Platelet production, clearance and distribution in patients with idiopathic thrombocytopenic purpura].
Isaka Y; Kambayashi J; Kimura K; Uehara A; Hashikawa K; Matsumoto M; Kamada T; Imaizumi M; Ashida K; Nakayama H
Kaku Igaku; 1990 Aug; 27(8):855-61. PubMed ID: 2232354
[TBL] [Abstract][Full Text] [Related]
7. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and distribution in vivo of 111In-labelled autologous platelets in idiopathic thrombocytopenic purpura.
Schmidt KG; Rasmussen JW
Scand J Haematol; 1985 Jan; 34(1):47-56. PubMed ID: 3918342
[TBL] [Abstract][Full Text] [Related]
9. The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction.
Peters AM; Saverymuttu SH; Wonke B; Lewis SM; Lavender JP
Br J Haematol; 1984 Aug; 57(4):637-49. PubMed ID: 6430336
[TBL] [Abstract][Full Text] [Related]
10. The sequestration of 111-In-labelled autologous platelets and the efficiency of splenectomy.
Najean Y; Rain JD; Dufour V
Nouv Rev Fr Hematol (1978); 1991; 33(6):449-50. PubMed ID: 1818297
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphy with indium-111-labeled homologous (donor) platelets in the platelet transfusion refractory bone marrow transplant patient.
Hammersmith SM; Jacobson AF; Mankoff DA
J Nucl Med; 1997 Jul; 38(7):1135-8. PubMed ID: 9225806
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytokinetic studies in families with hereditary thrombocytopenia.
Fortýnová J; Bakos K; Vopatova M
Prog Clin Biol Res; 1990; 355():89-96. PubMed ID: 2281116
[No Abstract] [Full Text] [Related]
13. Quantitative platelet imaging and comparison of four mathematical models for the evaluation of platelet mean life span in patients with chronic immune thrombocytopenia.
Amuasi JH; Ferri P; Grossi A; Vannucchi L; Vannucchi AM; Ferrini PR
Haematologica; 1991; 76(2):104-8. PubMed ID: 1937166
[TBL] [Abstract][Full Text] [Related]
14. Splenic dynamics of indium-111 labeled platelets in idiopathic thrombocytopenic purpura.
Syrjälä MT; Savolainen S; Nieminen U; Gripenberg J; Liewendahl K; Ikkala E
J Nucl Med; 1989 Sep; 30(9):1546-9. PubMed ID: 2769406
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.
Ballem PJ; Segal GM; Stratton JR; Gernsheimer T; Adamson JW; Slichter SJ
J Clin Invest; 1987 Jul; 80(1):33-40. PubMed ID: 3597777
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the effect of immunoglobulin therapy in ITP.
Kawasugi K; Matsuda J; Abe T
Blut; 1989 Jul; 59(1):88-91. PubMed ID: 2752178
[TBL] [Abstract][Full Text] [Related]
17. [Value of preoperative thrombocyte marking in patients with idiopathic thrombocytopenic purpura].
Gietz M; Mempel W; Clemm C; Hiller E; Heim M; Wilmanns W
Klin Wochenschr; 1988 Jul; 66(14):633-8. PubMed ID: 3210658
[TBL] [Abstract][Full Text] [Related]
18. The kinetics of short-lived indium-111 radiolabelled platelets.
Peters AM; Saverymuttu SH; Bell RN; Lavender JP
Scand J Haematol; 1985 Feb; 34(2):137-45. PubMed ID: 4038814
[TBL] [Abstract][Full Text] [Related]
19. Platelet kinetics with indium-111 platelets: comparison with chromium-51 platelets.
Peters AM; Lavender JP
Semin Thromb Hemost; 1983 Apr; 9(2):100-14. PubMed ID: 6346489
[TBL] [Abstract][Full Text] [Related]
20. Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ.
Heyns Adu P; Badenhorst PN; Lötter MG; Pieters H; Wessels P; Kotzé HF
Blood; 1986 Jan; 67(1):86-92. PubMed ID: 3940554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
